Venrock Healthcare Capital Partners III reports acquisition of $644,711.28 in Lycia Therapeutics shares
LYCA•Venrock Healthcare Capital Partners III and related reporting owners acquired 25,004 Lycia Therapeutics shares valued at $644,711.28. Their reported beneficial ownership rose to 6,850,237 shares.
1. Ownership disclosure
Venrock Healthcare Capital Partners III and related reporting owners acquired 25,004 shares of Lycia Therapeutics common stock, bringing their reported beneficial ownership to 6,850,237 shares, held indirectly through funds.
